Liang Liu

ORCID: 0000-0001-5288-2023 · 2 papers in corpus
other 2025
Journal of family medicine and primary care ·doi:10.4103/jfmpc.jfmpc_952_25
observational 2015
Medicine ·doi:10.1097/md.0000000000000751

Serum carbohydrate antigen 19-9 (CA19-9) is widely used to predict the prognosis for pancreatic ductal adenocarcinoma (PDAC). However, hyperbilirubinemia and the CA19-9 nonsecretor phenotype restrict the usage of serum CA19-9 alone. The goa…